288 related articles for article (PubMed ID: 21519788)
1. miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer.
Tatarano S; Chiyomaru T; Kawakami K; Enokida H; Yoshino H; Hidaka H; Yamasaki T; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Int J Oncol; 2011 Jul; 39(1):13-21. PubMed ID: 21519788
[TBL] [Abstract][Full Text] [Related]
2. Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer.
Yamasaki T; Yoshino H; Enokida H; Hidaka H; Chiyomaru T; Nohata N; Kinoshita T; Fuse M; Seki N; Nakagawa M
Int J Oncol; 2012 Jun; 40(6):1821-30. PubMed ID: 22378464
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer.
Yoshino H; Enokida H; Chiyomaru T; Tatarano S; Hidaka H; Yamasaki T; Gotannda T; Tachiwada T; Nohata N; Yamane T; Seki N; Nakagawa M
Biochem Biophys Res Commun; 2012 Jan; 417(1):588-93. PubMed ID: 22178073
[TBL] [Abstract][Full Text] [Related]
4. Restoration of miR-517a expression induces cell apoptosis in bladder cancer cell lines.
Yoshitomi T; Kawakami K; Enokida H; Chiyomaru T; Kagara I; Tatarano S; Yoshino H; Arimura H; Nishiyama K; Seki N; Nakagawa M
Oncol Rep; 2011 Jun; 25(6):1661-8. PubMed ID: 21479368
[TBL] [Abstract][Full Text] [Related]
5. Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1.
Fuse M; Nohata N; Kojima S; Sakamoto S; Chiyomaru T; Kawakami K; Enokida H; Nakagawa M; Naya Y; Ichikawa T; Seki N
Int J Oncol; 2011 Apr; 38(4):1093-101. PubMed ID: 21258769
[TBL] [Abstract][Full Text] [Related]
6. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.
Fuse M; Kojima S; Enokida H; Chiyomaru T; Yoshino H; Nohata N; Kinoshita T; Sakamoto S; Naya Y; Nakagawa M; Ichikawa T; Seki N
J Hum Genet; 2012 Nov; 57(11):691-9. PubMed ID: 22854542
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma.
Moriya Y; Nohata N; Kinoshita T; Mutallip M; Okamoto T; Yoshida S; Suzuki M; Yoshino I; Seki N
J Hum Genet; 2012 Jan; 57(1):38-45. PubMed ID: 22089643
[TBL] [Abstract][Full Text] [Related]
9. microRNA-203 suppresses bladder cancer development by repressing bcl-w expression.
Bo J; Yang G; Huo K; Jiang H; Zhang L; Liu D; Huang Y
FEBS J; 2011 Mar; 278(5):786-92. PubMed ID: 21205209
[TBL] [Abstract][Full Text] [Related]
10. OncomiRs: the discovery and progress of microRNAs in cancers.
Cho WC
Mol Cancer; 2007 Sep; 6():60. PubMed ID: 17894887
[TBL] [Abstract][Full Text] [Related]
11. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
[TBL] [Abstract][Full Text] [Related]
12. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinoma.
Nohata N; Hanazawa T; Kikkawa N; Sakurai D; Sasaki K; Chiyomaru T; Kawakami K; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
Int J Oncol; 2011 Nov; 39(5):1099-107. PubMed ID: 21701775
[TBL] [Abstract][Full Text] [Related]
14. MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines.
Uchida Y; Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Urol Oncol; 2013 Jan; 31(1):115-23. PubMed ID: 21396852
[TBL] [Abstract][Full Text] [Related]
15. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.
Puerta-Gil P; García-Baquero R; Jia AY; Ocaña S; Alvarez-Múgica M; Alvarez-Ossorio JL; Cordon-Cardo C; Cava F; Sánchez-Carbayo M
Am J Pathol; 2012 May; 180(5):1808-15. PubMed ID: 22426337
[TBL] [Abstract][Full Text] [Related]
16. Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling.
Kawakami K; Enokida H; Tachiwada T; Gotanda T; Tsuneyoshi K; Kubo H; Nishiyama K; Takiguchi M; Nakagawa M; Seki N
Oncol Rep; 2006 Sep; 16(3):521-31. PubMed ID: 16865252
[TBL] [Abstract][Full Text] [Related]
17. The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.
Itesako T; Seki N; Yoshino H; Chiyomaru T; Yamasaki T; Hidaka H; Yonezawa T; Nohata N; Kinoshita T; Nakagawa M; Enokida H
PLoS One; 2014; 9(2):e84311. PubMed ID: 24520312
[TBL] [Abstract][Full Text] [Related]
18. Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles.
Lionetti M; Agnelli L; Mosca L; Fabris S; Andronache A; Todoerti K; Ronchetti D; Deliliers GL; Neri A
Genes Chromosomes Cancer; 2009 Jun; 48(6):521-31. PubMed ID: 19306352
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer.
Lee KH; Goan YG; Hsiao M; Lee CH; Jian SH; Lin JT; Chen YL; Lu PJ
Exp Cell Res; 2009 Sep; 315(15):2529-38. PubMed ID: 19501585
[TBL] [Abstract][Full Text] [Related]
20. Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer.
Oh HK; Tan AL; Das K; Ooi CH; Deng NT; Tan IB; Beillard E; Lee J; Ramnarayanan K; Rha SY; Palanisamy N; Voorhoeve PM; Tan P
Clin Cancer Res; 2011 May; 17(9):2657-67. PubMed ID: 21415212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
